Results 191 to 200 of about 58,715 (292)

Hepatic encephalopathy - therapy [PDF]

DMW - Deutsche Medizinische Wochenschrift, 2003
M, Wettstein, D, Häussinger
openaire   +2 more sources

Mechanisms of Gui Zhi Fu Ling Formula in Liver Fibrosis: Metabolomics and Gut Microbiota Analysis

eFood, Volume 7, Issue 3, June 2026.
Our study was based on the efficacy of the phenotype in an animal model and used multi‐omics to explore the mechanism of action of the compound. We found that Gui Zhi Fu Ling Formula may ameliorate hepatic fibrosis potentially associated with increased hepatic EPA and the expression of gut Pseudomonas.
Xiaoliang Deng, Yanqun Luo, Ying Gao, Yi Su, Haiping Xue, Tao Wu   +5 more
wiley   +1 more source

The Role of Neuroinflammation in the Pathogenesis of Hepatic Encephalopathy. [PDF]

J Immunol Res
Rhodes K, Wang Y, DeMorrow S, Gurumallesh P.   +3 more
europepmc   +1 more source

Tryptophan and Hepatic Encephalopathy

Gastroenterology, 1979
C, Cangiano, F, Rossi Fanelli, A, Cascino, L, Capocaccia   +3 more
openaire   +2 more sources

The Chemical Structures, Neuroprotective Effects, Structure–Activity Relationships, and Applications of Flavonoids, Phenolic Acids, Terpenoids, and Sterols in Dandelion: A Review

Food Science &Nutrition, Volume 14, Issue 6, June 2026.
This review systematically summarizes the chemical structures and structure–activity relationships of key bioactive compounds in dandelion, including flavonoids, phenolic acids, terpenoids, and sterols. It highlights their neuroprotective mechanisms against neuroinflammation and oxidative stress, while outlining their promising dual applications in the
Hongye Li, Bingchan Qu, Jiasu Wu, Menghan Sun, Youlin Xue, Tiejing Li, Chang Tan, Shan Wang, Chong Ning, Chongting Guo   +9 more
wiley   +1 more source

Becoming a Different Person: Living with Hepatic Encephalopathy as a Condition in Everyday Life-A Qualitative Explorative Study. [PDF]

Healthcare (Basel)
Hamberg MLS, Werge RP, Lauridsen SV, Thomsen TS.   +3 more
europepmc   +1 more source

Prevalence, Clinical Profiles, Disease Severity, and Patient Outcomes of Alcoholic Liver Disease in a Tertiary Care Hospital of Nepal

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Introduction Alcoholic liver disease (ALD) is an increasingly prevalent, chronic lifestyle‐related disease, which poses a significant global public health challenge. Timely detection and intervention are critical to reducing morbidity and mortality.
Bibek Joshi, Uma Challa, Aayush, Robert Hernandez, Kanchan Devkota, Priya Yadav, Rafael Jose Ramirez Dominguez, Anaya Jawad, Mohammed Abdul Mateen, Nagham Al Dirani   +9 more
wiley   +1 more source

Sociodemographic disparities in documented nonadherence to medication for hepatic encephalopathy: a National Inpatient Sample analysis. [PDF]

Ann Gastroenterol
Behrend C, Ali Y, Akambase JA, Goble SR, Leventhal TM.   +4 more
europepmc   +1 more source

Ivermectin Toxicity in Humans and Animals: Clinical Spectrum, Mechanisms, and Management

Journal of Applied Toxicology, Volume 46, Issue 6, Page 1856-1870, June 2026.
ABSTRACT Ivermectin is a widely used macrocyclic lactone with established efficacy against a broad range of parasitic infections in humans and animals and a long‐standing reputation for clinical safety. However, increasing evidence indicates that ivermectin can produce clinically relevant toxicity under specific conditions, particularly involving the ...
Serkan Yilmaz, Bayram Göktaş, İlker Ateş, Mustafa Çelik   +3 more
wiley   +1 more source

Evaluation of Quality of Life and Risk Factors in Patients With Covert Hepatic Encephalopathy Including Those With Hepatocellular Carcinoma. [PDF]

Cancer Diagn Progn
Ishikawa T, Ito R, Arita N, Matsuhashi Y, Honma T.   +4 more
europepmc   +1 more source